000 | 01960 a2200505 4500 | ||
---|---|---|---|
005 | 20250514215307.0 | ||
264 | 0 | _c20050929 | |
008 | 200509s 0 0 eng d | ||
022 | _a0007-1188 | ||
024 | 7 |
_a10.1038/sj.bjp.0706132 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTrifilieff, Alexandre | |
245 | 0 | 0 |
_aCGH2466, a combined adenosine receptor antagonist, p38 mitogen-activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti-inflammatory activities. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cApr 2005 |
||
300 |
_a1002-10 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemistry |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 3 |
650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 4 |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xchemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xchemistry |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
650 | 0 | 4 | _aPurinergic P1 Receptor Antagonists |
650 | 0 | 4 |
_aPyridines _xchemistry |
650 | 0 | 4 |
_aReceptors, Purinergic P1 _xmetabolism |
650 | 0 | 4 |
_aThiazoles _xchemistry |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
700 | 1 | _aKeller, Thomas H | |
700 | 1 | _aPress, Neil J | |
700 | 1 | _aHowe, Trevor | |
700 | 1 | _aGedeck, Peter | |
700 | 1 | _aBeer, David | |
700 | 1 | _aWalker, Christoph | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 144 _gno. 7 _gp. 1002-10 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0706132 _zAvailable from publisher's website |
999 |
_c15362411 _d15362411 |